A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.

The purpose of this work was to investigate the contribution of thermodynamics and mobility to the physical stability of two pharmaceutical glasses with similar glass transition temperatures (Tg), by comparing configurational thermodynamic quantities and molecular relaxation time constants (tau) at temperatures below Tg. Ritonavir and nifedipine were chosen as model glasses because they show excellent and poor physical stability, respectively. Although ritonavir and nifedipine have similar Tg values (50 and 46 degrees C, respectively), amorphous ritonavir is quite stable while nifedipine has been reported to crystallize at temperatures as low as 40 degrees C below Tg. Modulated temperature differential scanning calorimetry (MTDSC) was used to characterize both crystalline phases and freshly prepared glasses. The glasses were then annealed at Tg-Ta = 25 degrees C while monitoring the extent of relaxation and heat capacity change as a function of time via MTDSC. Configurational thermodynamic quantities (Gc, Hc, and Sc) and molecular relaxation time constants, tau, were calculated from the calorimetric data. Interestingly, the Gibbs free energy driving force for crystallization was nearly identical for the two compounds. The largest differences were found in the configurational entropy (Sc) values for the fresh glasses and in the Sc values over time. Configurational entropy values were approximately 50% higher for ritonavir. The tau values of freshly prepared glasses indicated that both materials had similar initial mobility at the annealing temperatures and the temperature dependence of tau was approximately Arrhenius, regardless of age. Although initial tau values were similar, the tau values after 3 days annealing were approximately sixfold greater for ritonavir. The relatively poor physical stability of nifedipine compared to ritonavir is attributed to both the lower entropic barrier to crystallization for fresh and annealed glass, and higher molecular mobility in aged glasses of nifedipine. These observations below Tg are consistent with the previous work on physical stability of amorphous pharmaceuticals performed above Tg.

[1]  Deliang Zhou,et al.  Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. , 2002, Journal of pharmaceutical sciences.

[2]  Ranko Richert,et al.  Dynamics of glass-forming liquids. V. On the link between molecular dynamics and configurational entropy , 1998 .

[3]  J. C. Tucker,et al.  Dependence of the glass transition temperature on heating and cooling rate , 1974 .

[4]  S. Yoshioka,et al.  The Physical Stability of Amorphous Nifedipine Determined by Isothermal Microcalorimetry. , 1995 .

[5]  G. Adam,et al.  On the Temperature Dependence of Cooperative Relaxation Properties in Glass‐Forming Liquids , 1965 .

[6]  Malcolm L. Williams,et al.  The Temperature Dependence of Mechanical and Electrical Relaxations in Polymers , 1955 .

[7]  I. Hodge.  Strong and fragile liquids — a brief critique , 1996 .

[8]  W. Kauzmann.  The Nature of the Glassy State and the Behavior of Liquids at Low Temperatures. , 1948 .

[9]  I. Hodge.  Effects of annealing and prior history on enthalpy relaxation in glassy polymers. 6. Adam-Gibbs formulation of nonlinearity , 1987 .

[10]  R. Hatley.  Glass fragility and the stability of pharmaceutical preparations--excipient selection. , 1997, Pharmaceutical development and technology.

[11]  Bruno C. Hancock,et al.  CHARACTERIZATION OF THE TIME SCALES OF MOLECULAR MOTION IN PHARMACEUTICALLY IMPORTANT GLASSES , 1999 .

[12]  K. Ngai,et al.  Relaxations in Complex Systems , 1984 .

[13]  O. S. Narayanaswamy.  A Model of Structural Relaxation in Glass , 1971 .

[14]  G. P. Johari.  The entropy loss on supercooling a liquid and anharmonic contributions , 2002 .

[15]  I. Hodge.  Enthalpy relaxation and recovery in amorphous materials , 1994 .

[16]  Y Aso,et al.  Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times. , 2000, Journal of pharmaceutical sciences.

[17]  G. P. Johari.  A resolution for the enigma of a liquid’s configurational entropy-molecular kinetics relation , 2000 .

[18]  G. Scherer.  Use of the Adam‐Gibbs Equation in the Analysis of Structural Relaxation , 2006 .

[19]  M. Pikal,et al.  Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability. , 1978, Journal of pharmaceutical sciences.

[20]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[21]  G. Fulcher,et al.  ANALYSIS OF RECENT MEASUREMENTS OF THE VISCOSITY OF GLASSES , 1925 .

[22]  S Capaccioli,et al.  Pressure dependence of structural relaxation time in terms of the Adam-Gibbs model. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.

[23]  R. Landel,et al.  The Temperature Dependence of Relaxation Mechanisms in Amorphous Polymers and Other Glass-Forming Liquids , 1955 .

[24]  H. N. Ritland,et al.  Limitations of the Fictive Temperature Concept , 1956 .

[25]  C. T. Moynihan,et al.  Estimation of activation energies for structural relaxation and viscous flow from DTA and DSC experiments , 1996 .

[26]  G. Scherer.  Viscous Sintering of a Bimodal Pore‐Size Distribution , 1984 .

[27]  S. Dev,et al.  Further considerations of non symmetrical dielectric relaxation behaviour arising from a simple empirical decay function , 1971 .

[28]  Bruno C. Hancock,et al.  Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures , 1995, Pharmaceutical Research.

[29]  S. Petit,et al.  The Amorphous State , 2006 .

[30]  G. Tammann,et al.  Die Abhängigkeit der Viscosität von der Temperatur bie unterkühlten Flüssigkeiten , 1926 .

[31]  I. Hodge,et al.  Physical Aging in Polymer Glasses , 1995, Science.

[32]  H. Vogel,et al.  Das Temperaturabhangigkeitsgesetz der Viskositat von Flussigkeiten , 1921 .

[33]  A. Q. Tool,et al.  RELATION BETWEEN INELASTIC DEFORMABILITY AND THERMAL EXPANSION OF GLASS IN ITS ANNEALING RANGE , 1946 .

[34]  Pablo G. Debenedetti,et al.  Supercooled liquids and the glass transition , 2001, Nature.

[35]  J. H. Gibbs,et al.  Nature of the Glass Transition and the Glassy State , 1958 .

[36]  S. Duddu,et al.  The Relationship Between Protein Aggregation and Molecular Mobility Below the Glass Transition Temperature of Lyophilized Formulations Containing a Monoclonal Antibody , 1997, Pharmaceutical Research.

[37]  Y Aso,et al.  Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by (13)C nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature. , 2001, Journal of pharmaceutical sciences.

[38]  C. Angell.  Why C1 = 16-17 in the WLF equation is physical - And the fragility of polymers , 1997 .

[39]  Graham Williams,et al.  Non-symmetrical dielectric relaxation behaviour arising from a simple empirical decay function , 1970 .